|
An in vivo multiplex model to study gene-environment interaction in Parkinsons Disease |
1K99ES033723-01A1 |
|
NIEHS |
2022 |
|
Interaction of Pyrethroid Exposure and the Microbiome on Parkinsons Disease related Pathologies |
1R01ES032440-01A1 |
|
NIEHS |
2022 |
|
Microglial Hv1 Proton Channel as a Mediator of Environmentally-Induced Neuroinflammation and Neurodegeneration |
1R01ES033892-01 |
|
NIEHS |
2022 |
|
Characterizing the link between multiple environmental exposures and Parkinsons disease exacerbation |
1R01ES034373-01 |
|
NIEHS |
2022 |
|
Investigation of AhR Ligands on FcGamma Receptor Signaling: Consequences of Antibody Suppression |
2R15ES027650-02 |
|
NIEHS |
2022 |
|
Neuroinflammation and developmental vulnerability to manganese toxicity |
3R01ES021656-10S1 |
|
NIEHS |
2022 |
|
Microbiome, Environment, and Parkinsons disease (MEP) PESTICIDE EXPOSURES AND THE GUT MICROBIOME IN PARKINSONS DISEASE |
3R01ES031106-03S1 |
|
NIEHS |
2022 |
|
Neurotoxic and neurodegenerative risks from chronic exposure to metal mixtures in e-cigarette aerosol |
3R01ES032954-02S1 |
|
NIEHS |
2022 |
|
Sensory Mechanisms of Cadmium-Induced Behavioral Disorders Across Generations |
4R00ES030398-04 |
|
NIEHS |
2022 |
|
Elucidation of mitochondrial mechanisms critical to mediating PFAS neurotoxicity |
5K99ES032488-02 |
|
NIEHS |
2022 |